vs
Side-by-side financial comparison of Idaho Strategic Resources, Inc. (IDR) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
Idaho Strategic Resources, Inc. is the larger business by last-quarter revenue ($14.6M vs $12.6M, roughly 1.2× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs 64.3%, a 186.4% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 92.0%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 57.2%).
Idaho Strategic Resources, Inc.IDREarnings & Financial Report
Idaho Strategic Resources, Inc. is a U.S.-based natural resource company focused on the exploration, development, and production of critical and strategic minerals. Primarily operating in Idaho, it targets rare earth elements, gold, silver, and other high-demand minerals, supplying products to the clean energy, defense, and industrial manufacturing sectors across North America.
IDR vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $14.6M | $12.6M |
| Net Profit | $9.4M | $31.5M |
| Gross Margin | 68.5% | — |
| Operating Margin | 62.4% | — |
| Net Margin | 64.3% | 250.7% |
| Revenue YoY | 92.0% | 24080.8% |
| Net Profit YoY | 220.6% | 250.9% |
| EPS (diluted) | $0.62 | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $14.6M | $12.6M | ||
| Q3 25 | $11.1M | $0 | ||
| Q2 25 | $9.5M | $0 | ||
| Q1 25 | $7.3M | $12.0K | ||
| Q4 24 | $7.6M | $52.0K | ||
| Q3 24 | $6.2M | $65.0K | ||
| Q2 24 | $6.1M | $114.0K | ||
| Q1 24 | $5.9M | $140.0K |
| Q4 25 | $9.4M | $31.5M | ||
| Q3 25 | $3.0M | $-7.4M | ||
| Q2 25 | $2.8M | $-1.7M | ||
| Q1 25 | $1.6M | $-13.9M | ||
| Q4 24 | $2.9M | — | ||
| Q3 24 | $1.6M | $-17.1M | ||
| Q2 24 | $2.2M | $-17.9M | ||
| Q1 24 | $2.2M | $-12.7M |
| Q4 25 | 68.5% | — | ||
| Q3 25 | 63.6% | — | ||
| Q2 25 | 57.8% | — | ||
| Q1 25 | 50.8% | — | ||
| Q4 24 | 53.3% | — | ||
| Q3 24 | 48.7% | — | ||
| Q2 24 | 50.2% | — | ||
| Q1 24 | 48.1% | — |
| Q4 25 | 62.4% | — | ||
| Q3 25 | 23.4% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | 19.3% | -122758.3% | ||
| Q4 24 | 36.2% | — | ||
| Q3 24 | 23.4% | -28604.6% | ||
| Q2 24 | 34.2% | -16720.2% | ||
| Q1 24 | 36.3% | -9987.1% |
| Q4 25 | 64.3% | 250.7% | ||
| Q3 25 | 26.8% | — | ||
| Q2 25 | 29.2% | — | ||
| Q1 25 | 22.1% | -115550.0% | ||
| Q4 24 | 38.5% | — | ||
| Q3 24 | 25.8% | -26380.0% | ||
| Q2 24 | 35.2% | -15668.4% | ||
| Q1 24 | 36.8% | -9049.3% |
| Q4 25 | $0.62 | $0.56 | ||
| Q3 25 | $0.20 | $-0.13 | ||
| Q2 25 | $0.20 | $-0.03 | ||
| Q1 25 | $0.12 | $-0.25 | ||
| Q4 24 | $0.21 | — | ||
| Q3 24 | $0.12 | $-0.32 | ||
| Q2 24 | $0.17 | $-0.33 | ||
| Q1 24 | $0.17 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $40.3M |
| Total DebtLower is stronger | $2.3M | — |
| Stockholders' EquityBook value | $108.2M | $59.0M |
| Total Assets | $116.2M | $68.9M |
| Debt / EquityLower = less leverage | 0.02× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $40.3M | ||
| Q3 25 | — | $48.6M | ||
| Q2 25 | — | $31.2M | ||
| Q1 25 | — | $48.9M | ||
| Q4 24 | — | $52.9M | ||
| Q3 24 | — | $76.3M | ||
| Q2 24 | $6.3M | $63.5M | ||
| Q1 24 | $5.3M | $82.3M |
| Q4 25 | $2.3M | — | ||
| Q3 25 | $3.0M | — | ||
| Q2 25 | $3.3M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.7M | — | ||
| Q3 24 | $2.9M | — | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $3.3M | — |
| Q4 25 | $108.2M | $59.0M | ||
| Q3 25 | $74.3M | $26.5M | ||
| Q2 25 | $49.3M | $32.8M | ||
| Q1 25 | $39.8M | $33.8M | ||
| Q4 24 | $37.7M | $46.1M | ||
| Q3 24 | $33.1M | $65.5M | ||
| Q2 24 | $25.4M | $80.5M | ||
| Q1 24 | $21.6M | $96.2M |
| Q4 25 | $116.2M | $68.9M | ||
| Q3 25 | $83.1M | $54.2M | ||
| Q2 25 | $57.7M | $62.1M | ||
| Q1 25 | $48.1M | $77.7M | ||
| Q4 24 | $44.0M | $110.5M | ||
| Q3 24 | $40.8M | $135.2M | ||
| Q2 24 | $32.2M | $149.9M | ||
| Q1 24 | $28.7M | $167.7M |
| Q4 25 | 0.02× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.07× | — | ||
| Q1 25 | 0.09× | — | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | 0.09× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.15× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.7M | $-8.4M |
| Free Cash FlowOCF − Capex | $8.2M | — |
| FCF MarginFCF / Revenue | 56.0% | — |
| Capex IntensityCapex / Revenue | 17.7% | — |
| Cash ConversionOCF / Net Profit | 1.15× | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | $12.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.7M | $-8.4M | ||
| Q3 25 | $2.4M | $17.4M | ||
| Q2 25 | $3.5M | $-17.7M | ||
| Q1 25 | $2.4M | $-4.0M | ||
| Q4 24 | $3.2M | $-23.4M | ||
| Q3 24 | $2.5M | $12.8M | ||
| Q2 24 | $2.6M | $-18.7M | ||
| Q1 24 | $2.6M | $5.9M |
| Q4 25 | $8.2M | — | ||
| Q3 25 | $709.8K | — | ||
| Q2 25 | $2.5M | — | ||
| Q1 25 | $1.0M | — | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $1.9M | — | ||
| Q2 24 | $2.4M | — | ||
| Q1 24 | $2.3M | — |
| Q4 25 | 56.0% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 26.5% | — | ||
| Q1 25 | 13.8% | — | ||
| Q4 24 | 28.0% | — | ||
| Q3 24 | 30.4% | — | ||
| Q2 24 | 38.7% | — | ||
| Q1 24 | 38.3% | — |
| Q4 25 | 17.7% | — | ||
| Q3 25 | 15.3% | — | ||
| Q2 25 | 10.8% | — | ||
| Q1 25 | 19.4% | — | ||
| Q4 24 | 13.6% | — | ||
| Q3 24 | 9.8% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 5.5% | — |
| Q4 25 | 1.15× | -0.26× | ||
| Q3 25 | 0.81× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.08× | — | ||
| Q3 24 | 1.56× | — | ||
| Q2 24 | 1.22× | — | ||
| Q1 24 | 1.19× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
